Evidence map›Paper›PMID 38476985›Full record

ArticleMedicine international

Clinical genomic profiling of malignant giant cell tumor of bone: A retrospective analysis using a real‑world database.

Yusuke Tsuda, Koichi Okajima, Yuki Ishibashi, Liuzhe Zhang, Toshihide Hirai, Hidenori Kage, Aya Shinozaki-Ushiku, Katsutoshi Oda, Sakae Tanaka, Hiroshi Kobayashi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yusuke TsudaDepartment of Orthopedic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Koichi OkajimaDepartment of Orthopedic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Yuki IshibashiDepartment of Orthopedic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Liuzhe ZhangDepartment of Orthopedic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Toshihide HiraiDepartment of Orthopedic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Hidenori KageNext-Generation Precision Medicine Development Laboratory, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Aya Shinozaki-UshikuDivision of Integrative Genomics, The University of Tokyo, Tokyo 113-8655, Japan.
Katsutoshi OdaDivision of Integrative Genomics, The University of Tokyo, Tokyo 113-8655, Japan.
Sakae TanakaDepartment of Orthopedic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Hiroshi KobayashiDepartment of Orthopedic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
University of Tokyo Hospital · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant giant cell tumor of bone (GCTB) is identified by the presence of multinucleated giant cells, with an aggressive behavior and a high risk of metastasis, which has not been genetically characterized in detail. H3 histone family member 3A (

Indexed as

genomemalignant giant cell tumor of boneMAPK signalingsarcoma

Identifiers

PMID38476985
PMCPMC10928650
OpenAlexW4392012375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.